Unraveling #JPM24: The Impact for You and the Industry
Available on-demand
Sign up today to join Citeline’s expert panel of reporters and analysts as they explore the biggest deals and trends shaping 2024 and discuss what they mean for you.
We'll cover everything from major deals to cutting-edge technologies and therapeutic areas, providing you with comprehensive insights into the future landscape of our industry.
- Uncover the biggest deals, mergers and IPOs announced at JPM24
- Explore the excitement surrounding new obesity drugs
- Identify key technologies for investment and AI advancement
- Discover why Antibody-drug conjugates (ADCs) stole the limelight
- Embrace the renewed optimism around Cell and Gene therapies (CGTs)
Meet the Speakers
Mandy Jackson
Managing Editor, US Commercial News
Scrip
Jessica Merrill
Senior Editor
Scrip
Puru Gaur
Senior Commercial Consultant
Norstella
Moderator
David Wild
Pharma and Biotech reporter
In Vivo
